Company · CIK 1720725

# Oyster Point Pharma, Inc.

| CIK | [1720725](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001720725) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | NJ |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-12-03 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-249881 | Shelf Effective | 2020-11-05 | 2023-01-05 | 4 |
| 333-238194 | Registered company Final prospectus | 2020-05-12 | 2020-05-18 | 4 |
| 333-234104 | IPO Final prospectus | 2019-10-04 | 2019-10-31 | 5 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-01-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1720725/999999999523000038/9999999995-23-000038-index.htm) Declared effective | 333-249881 | 9999999995-23-000038 |
| 2020-12-18 | [424B5](https://www.sec.gov/Archives/edgar/data/1720725/000119312520321531/0001193125-20-321531-index.htm) Shelf takedown | 333-249881 | 0001193125-20-321531 |
| 2020-11-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1720725/999999999520003193/9999999995-20-003193-index.htm) Declared effective | 333-249881 | 9999999995-20-003193 |
| 2020-11-05 | [S-3](https://www.sec.gov/Archives/edgar/data/1720725/000119312520286956/0001193125-20-286956-index.htm) Shelf registered | 333-249881 | 0001193125-20-286956 |
| 2020-05-18 | [424B4](https://www.sec.gov/Archives/edgar/data/1720725/000119312520144236/0001193125-20-144236-index.htm) Final prospectus | 333-238194 | 0001193125-20-144236 |
| 2020-05-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1720725/999999999520001166/9999999995-20-001166-index.htm) Declared effective | 333-238194 | 9999999995-20-001166 |
| 2020-05-14 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1720725/000119312520142919/0001193125-20-142919-index.htm) Amendment | 333-238194 | 0001193125-20-142919 |
| 2020-05-12 | [S-1](https://www.sec.gov/Archives/edgar/data/1720725/000119312520140387/0001193125-20-140387-index.htm) Registration filed | 333-238194 | 0001193125-20-140387 |
| 2020-04-27 | [DRS](https://www.sec.gov/Archives/edgar/data/1720725/000095012320003618/0000950123-20-003618-index.htm) Draft made public | 377-03142 | 0000950123-20-003618 |
| 2019-10-31 | [424B4](https://www.sec.gov/Archives/edgar/data/1720725/000119312519280598/0001193125-19-280598-index.htm) Final prospectus | 333-234104 | 0001193125-19-280598 |
| 2019-10-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1720725/999999999519002429/9999999995-19-002429-index.htm) Declared effective | 333-234104 | 9999999995-19-002429 |
| 2019-10-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1720725/000119312519270374/0001193125-19-270374-index.htm) Amendment | 333-234104 | 0001193125-19-270374 |
| 2019-10-15 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1720725/000119312519267294/0001193125-19-267294-index.htm) Amendment | 333-234104 | 0001193125-19-267294 |
| 2019-10-04 | [S-1](https://www.sec.gov/Archives/edgar/data/1720725/000119312519262771/0001193125-19-262771-index.htm) Registration filed | 333-234104 | 0001193125-19-262771 |
| 2019-07-25 | [DRS](https://www.sec.gov/Archives/edgar/data/1720725/000095012319006616/0000950123-19-006616-index.htm) Draft made public | 377-02750 | 0000950123-19-006616 |

[All filings of this company](https://equitycapital.markets/filings?cik=1720725) · [CSV](https://equitycapital.markets/filings.csv?cik=1720725)

---
Source page: https://equitycapital.markets/company/1720725 · Data: U.S. SEC EDGAR · CC BY 4.0